Status:
COMPLETED
Elongation of Foveal Tissue After Macular Hole Surgery
Lead Sponsor:
Samsung Medical Center
Conditions:
Macular Holes
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
In our experience, elongation of foveal tissue after macular hole surgery which was undetectable by conventional time-domain optical coherence tomography was often observed on spectral-domain optical ...
Eligibility Criteria
Inclusion
- Patients who were diagnosed with idiopathic macular hole
Exclusion
- traumatic macular hole
- evidence of ocular inflammation, diabetic retinopathy, hypertensive retinopathy, and retinal vasculitis, media opacity that would influence visual acuity or preclude acquisition of clear spectral domain optical coherence tomography images
- presence of cataract judged to affect visual function, -6.0 diopters or more of spherical equivalent, prominent staphyloma
- history of intraocular surgery other than uncomplicated cataract surgery, other ocular diseases that may influence the macular microstructure or visual function
- patients with indistinct intraretinal structure on spectral domain optical coherence tomography images
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01471912
Start Date
September 1 2009
End Date
October 1 2011
Last Update
November 17 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710